Ken Koon Wong

@kenkoonwong.bsky.social

data science enthusiast #rstats. infectious disease provider. lazy gardener. tai chi practitioner. life long learner. views are my own. RT or like != endorsement. https://www.kenkoonwong.com/

I'm so happy to announce version 2.0.0 of my #Rstats package WeightIt is out on CRAN! New features: censoring weights, multilevel propensity scores, improved weights for continuous treatments, bias-reduced ordinal and multinomial models, M-estimation in subgroups Check out the website below!

Weighting for Covariate Balance in Observational Studies

Generates balancing weights for causal effect estimation in observational studies with binary, multi-category, or continuous point or longitudinal treatments by easing and extending the functionality ...

ngreifer.github.io

Tongue swabs (3.8% yield) nearly matched sputum tests (4.1%) in TB diagnosis among 1639 people; 100% gave swabs vs 84.7% sputum. Non-inferior, aids testing where sputum hard. 🦷🦠

Diagnostic Yield of Tongue Swab- Compared to Sputum-Based Molecular Testing for Tuberculosis in Four High-Burden Countries

Tongue swabs are a promising alternative specimen for tuberculosis (TB) diagnosis. Although test specificity exceeds 98%, sensitivity is lower than sputum-based molecular testing. We investigated whether the use of tongue swabs could increase sample availability, resulting in similar diagnostic yield.MethodsIn this cross-sectional study (July 2024–January 2025), we screened consecutive people with presumptive TB at health centers in the Philippines, Vietnam, Uganda, and Zambia. Participants were asked to provide tongue swabs and referred for routine sputum collection. Tongue swabs were tested in research laboratories using the MiniDock MTB Test (Guangzhou Pluslife Biotech Co., Ltd., China); sputum was tested using WHO-recommended molecular testing per national guidelines. We compared diagnostic yield, defined as proportion of positive test results among all participants, between tongue swab- and sputum-based molecular testing with a prespecified 3.0% non-inferiority margin.ResultsOf 1639 participants, 851 (51.9%) were female, 415 (25.3%) were diagnosed with HIV, and 132 (8.1%) were children <5 years. All provided tongue swabs, but only 1389 (84.7%) produced sputum. Diagnostic yield was 3.8% (63/1639) for tongue swabs and 4.1% (68/1639) for sputum-based (68/1639, 4.1%) molecular testing. The difference (0.3%, 95% CI −0.6 to +1.2) was within the prespecified non-inferiority margin. Results were consistent across countries and key subgroups (age, sex, and HIV status).ConclusionsTongue swab-based molecular testing with MiniDock MTB achieved non-inferior diagnostic yield compared with sputum-based molecular testing. These findings support scale-up of swab-based platforms as a cost-efficient alternative, particularly where sputum collection is challenging or smear microscopy remains the primary diagnostic method.

academic.oup.com

31% pts had ESBL E. coli colonization; 19.4% with colonization got SSIs vs 1.5% without (OR 15.36). Colonization linked to higher SSI risk (aOR 16.53).🦠🦴#orthopedics

Incidence and outcomes for colonization of multidrug-resistance organisms (MDROs) among patients undergoing elective orthopedic surgery

View abstract Objective:To evaluate the incidence, risk factors, and outcomes associated with multidrug-resistant organisms (MDROs) colonization in patients undergoing elective orthopedic surgery at the Thammasat University Hospital.Methods:We conducted a prospective MDROs surveillance screening (swabs from the nose, throat, groin, and rectum) in patients undergoing orthopedic surgery. MDROs were defined as extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacteria (GNB), carbapenem-resistant Enterobacterales, methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci. The incidence of MDROs colonization, risk factors, and outcomes including surgical site infections (SSIs) were assessed. Postoperative SSIs were compared between patients with and without MDROs colonization.Results:Of 384 swabs tested from 96 patients, ESBL-producing Escherichia coli was identified in 38 isolates (31 rectal swabs and 7 groin swabs) from 31 patients (32.3%). Only one patient had a history of admission within the previous year. Majority of procedures involved prosthetic implantation (77.1%) including total knee arthroplasty (30.2%). Seven patients (7.3%) developed SSIs without microbiological confirmation. The incidence of SSIs was higher among patients with ESBL-producing E. coli colonization compared to patients without colonization (6/31, 19.4% vs. 1/65, 1.5%; P = .004; odds ratio, 15.36; 95% CI 1.7–356.3). From the multivariate logistic regression analysis, preoperative ESBL-producing E. coli colonization was associated with SSIs (P = .014, adjusted odds ratio 16.53, 95% CI 1.78–153.44).Conclusion:Preoperative ESBL-producing E. coli colonization was common among patients undergoing orthopedic surgery and possibly increased risk of SSIs. Further studies for multidrug-resistant GNB screening, surgical outcomes, and antibiotic prophylaxis modification should be considered in endemic regions.

cambridge.org

TBM study: High-dose rifampicin ↑ linezolid clearance by 34.2%, lowering CNS/plasma levels. 1200mg QD fails; 600mg BID maintains therapy. Optimizing dose is key.💊📉34.2%

Impact of High-Dose Rifampicin on Linezolid Pharmacokinetics in Tuberculous Meningitis

Tuberculous meningitis (TBM), a severe form of extrapulmonary tuberculosis, requires sustained therapeutic drug concentrations in the central nervous system (CNS). Linezolid is a promising treatment for TBM due to excellent CNS penetration and bactericidal activity against Mycobacterium tuberculosis. However, co-administration with rifampicin may alter linezolid pharmacokinetics (PK), potentially reducing efficacy due to drug–drug interactions.MethodsWe utilized data from the Adjunctive Linezolid for the Treatment of TubERculous Meningitis trial, a phase II study evaluating high-dose (35 mg/kg) versus standard-dose (10 mg/kg) rifampicin, with or without linezolid, in adults with TBM. Plasma sampling occurred on days 1 (dense) and 14 (sparse) with cerebrospinal fluid (CSF) sampling. Population PK modeling and simulation were employed to characterize linezolid disposition in plasma and CSF.ResultsEighteen participants contributed 73 plasma and 30 CSF samples to the analysis. Plasma concentrations were best described by a 1-compartment model with linear absorption and clearance, linked to a CSF compartment. High-dose rifampicin increased linezolid clearance by 34.2%, reducing systemic and CNS exposure. Simulations demonstrated that 1200 mg once-daily dosing failed to maintain therapeutic plasma and CSF linezolid concentrations when co-administered with high-dose rifampicin. In contrast, 600 mg twice-daily achieved adequate linezolid exposures even with higher rifampicin doses.ConclusionsHigh-dose rifampicin significantly increases linezolid clearance, reducing plasma and CSF drug levels. However, twice-daily linezolid may mitigate this effect and maintain therapeutic concentrations. These findings underscore the importance of optimizing linezolid dosing when used with rifampicin in TBM and support evaluation in larger studies to guide treatment strategies.

academic.oup.com

140 pts with MBL-BSI in Argentina: 41% mortality. CAZ/AVI+ATM tx ↓death risk (OR 0.18), INCREMENT-CPE≥8 ↑death risk (OR 3.63). K.pneumoniae 75%, Serratia 12%.🦠💉

Clinical Characteristics and Outcomes of Bloodstream Infections Caused by Metallo-β-Lactamase–Producing Enterobacterales in Argentina: A Subanalysis of the EMBARCAR Prospective Multicenter Cohort Study

Bloodstream infections (BSI) caused by metallo-beta-lactamase (MBL)-producing Enterobacterales (E) are associated with high mortality. However, in most Latin American countries there is a lack of clinical and microbiological data on BSI caused by MBL-E.MethodsThis preplanned subgroup analysis of the multicenter, observational, prospective EMBARCAR study focused on adult patients with BSI caused by MBL-E in Argentina. Logistic regression adjusted by propensity scores (PS) for the treatment with ceftazidime-avibactam plus aztreonam (CAZ/AVI plus ATM) were used to identify variables associated with mortality.ResultsA total of 140 patients with BSI caused by MBL-producing Enterobacterales were included. Median age was 59 years (IQR 46–70), and most patients were male (61%). Most frequent comorbidities were diabetes 23%, class III obesity 19%, and chronic renal failure 19%. Two thirds of patients were hospitalized in critical care units, 60% required mechanical ventilation and 38% presented with shock. Most frequent isolated microorganisms were Klebsiella pneumoniae (75%) and Serratia marcescens (12%). Most patients (64%) received combination therapy and 23% received CAZ/AVI plus ATM. Thirty-day mortality was 41%. In the multivariate PS adjusted analysis, INCREMENT-CPE score ≥8 was associated with increased risk of mortality (odds ratio [OR] 3.63; 95% CI: 1.13, 11.7), while CAZ/AVI plus ATM therapy with a lower risk of death (OR 0.18; 95% CI: .05, .58).ConclusionsIn summary, BSI due to MBL-producing Enterobacterales resulted in a high mortality rate in our country. The use of CAZ/AVI plus ATM was associated with a decreased mortality. Better access to these antibiotics should be granted.

academic.oup.com

Important data on HBV with LA-CAB/RPV from France 🇫🇷 -1247 received LA-CAB/RPV from 5 health depts -290 (7.5%) had ➖ HBVsAB of which 75 (6.0%) had ➕ anti-HBc Abs. 8 developed acute HBV on therapy: 3️⃣ new infection 5️⃣ relapse (3 of which isolated HBVcAB pos) academic.oup.com/cid/advance-... #IDSky

Acute Hepatitis B among PWH Switched to Long-Acting Cabotegravir/Rilpivirine: The Context Matters

Rémi Rouget, Nadia Valin, Antoine Bachelard, Christia Palacios, Amélie Chabrol, Antoine Faycal, Marc-Antoine Valantin, Valérie Pourcher, Jade Ghosn, Gilles

academic.oup.com

CzIE found in 35.5% MSSA pts; 90-day mortality 20.7% vs 22.2% (ns). CzIE ↑micro. failure: 20.7% vs 6.0%, HR=3.12 (p=0.0065). CzIE testing may guide tx.🦠📊

Cefazolin inoculum effect and cefazolin microbiological treatment failure in serious methicillin-susceptible Staphylococcus aureus infections: A multi-center retrospective cohort study

It remains unclear if cefazolin inoculum effect (CzIE) translates to poorer clinical outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) infections who were treated with cefazolin.MethodsThis retrospective cohort study across five hospitals in Ontario, Canada from 2021 to 2025 included adult patients who received cefazolin treatment for serious MSSA infection based on blood or deep sterile site culture growth. CzIE was defined as a ≥4 fold increase in cefazolin minimum inhibitory concentration to ≥16 μg/mL at a high inoculum based on broth microdilution assay. Patients were followed to 90 days. Primary outcome was all-cause mortality. Secondary outcome was microbiological treatment failure based on culture growth of MSSA after one week of cefazolin treatment. Potential confounders were adjusted using propensity score weighting and a competing risk model for microbiological treatment failure was used to account for mortality as a competing event.ResultsOf 259 patients, 92 (35.5%) patients had an MSSA isolate that displayed CzIE. The 90-day mortality rate was 19/92 (20.7%) and 37/167 (22.2%) in the CzIE positive and negative group respectively with adjusted risk difference of 0.6% (95% CI -9.0% to 10.2%, p=0.9060). Microbiological treatment failure occurred in 19/92 (20.7%) and 10/167 (6.0%) from the CzIE positive and negative group respectively with adjusted sub-distribution hazard ratio of 3.12 (95% CI 1.38 to 7.08, p=0.0065) in a competing risk model.ConclusionsCzIE was associated with a significantly increased risk of microbiological treatment failure. CzIE testing may be useful in guiding antibiotic treatment for serious MSSA infections.

academic.oup.com

Novel dried urine strips for chlamydia/gonorrhea testing showed >91% sensitivity, >98% specificity, stable at varied temps, enabling easy self-collection and mail-in for STI screening 📬🦠

Development and evaluation of dried urine strip for genital chlamydia and gonorrhea testing

ABSTRACTHere, we developed and evaluated a filter-paper urine collection method for chlamydia and gonorrhea testing. Dried urine strips (DUS) were developed to fit into the sample collection tube used for high throughput Hologic Aptima Combo 2 assay, minimizing processing post-sample collection. Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) bacterial stock dilutions were used to assess DUS performance and long-term stability at different temperature conditions. DUS diagnostic performance was evaluated against urine samples with Aptima Combo 2 Assay and an in-house RT-PCR method for CT and NG detection utilizing residual diagnostic urine specimens (n = 60 CT and NG negative, n = 50 CT-positive and n = 55 NG-positive, including 5 CT/NG dual-positive). Replacing the overnight strip drying step with use of additional desiccants was evaluated in order to reduce barriers to self-sample collection. We observed a high degree of diagnostic accuracy (>91% sensitivity and >98% specificity), compared to traditional urine samples across all evaluated DUS preparation and storage methods. DUS samples demonstrated high stability for prolonged periods at tested temperature storage conditions with some loss in sensitivity at lower bacterial loads. While drying of the sample was crucial to preserve sample integrity and improve recovery post-elution, placing the DUS directly into the sample storage bag with additional desiccants did not negatively impact diagnostic performance. DUS specimens were shown suitable for downstream CT genotyping and NG sequence typing. The developed DUS represents an accurate and stable sample collection method for CT and NG diagnostic testing and downstream pathogen characterization.IMPORTANCEInnovative sampling methods that are convenient, accurate, and user-friendly are crucial to increase sexually transmitted infection (STI) testing uptake. This study establishes a novel dried urine strip sample collection method for chlamydia and gonorrhea testing and downstream molecular characterization. Results show no inferiority of dried urine strips compared to urine, with regard to diagnostic performance, when analyzed using molecular in-house and commercial assays for chlamydia and gonorrhea detection. A dried urine strip sample collection method for chlamydia and gonorrhea testing offers significant advantages in resource-limited or stigmatized settings; it enables self-collection, mail-in return, and long-term storage at ambient temperatures, making it ideal for reaching underserved populations. The broader public health impact is the expansion of STI screening access and reduction in STI transmission by offering a discreet, scalable alternative to traditional specimen collection.

journals.asm.org

🦠 Made up my own memory tricks — Gatekeeper, Dumpster, Repressor — to understand AmpC mechanics. Discovered Serratia has 2 recyclers (AmpD + AmiD2) making derepression harder, and E. coli lacks AmpR so AmpC stays silent! Probably not textbook, but it helped me learn 🙌 #idsky #ampc

Learning Chromosomal AmpC beta-lactamase Producing Organisms And Its Mechanics | Everyday Is A School Day

🦠 Made up my own memory tricks — Amp(G)atekeeper, Amp(D)umpster, Amp(R)epressor — to understand AmpC mechanics. Learnt Serratia has 2 recyclers (AmpD + AmiD2) making derepression harder, and E. coli l...

kenkoonwong.com

CROs, esp. CP strains, threaten global health 🦠. 2025 CLSI M100 now urges carbapenemase testing for resistant Enterobacterales to guide therapy & stewardship 🚨🔬.

The shift from “MIC-Only” back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance

ABSTRACTCarbapenem-resistant organisms (CROs) pose a major threat to global health due to limited therapeutic options and their capacity for rapid dissemination. Among these, carbapenemase-producing (CP) strains are of greatest concern, as they hydrolyze most β-lactams, and carbapenemase genes are readily spread via mobile genetic elements. Historically, clinical laboratories relied solely on minimal inhibitory concentration (MIC) results and interpretive criteria to guide therapy, with carbapenemase testing performed mainly for epidemiologic purposes. However, changing carbapenemase epidemiology, the introduction of enzyme-specific novel β-lactam combination agents for treatment, and updated Clinical and Laboratory Standards Institute (CLSI) guidance have renewed the importance of carbapenemase testing among carbapenem-resistant Enterobacterales. The 2025 CLSI M100 update now recommends carbapenemase testing for most Enterobacterales resistant to at least one carbapenem, emphasizing differentiation of key enzymes, such as KPC, NDM, and OXA-48-like, to inform therapeutic decisions and support antimicrobial stewardship. This minireview summarizes the evolution of CLSI guidance from early breakpoint establishment through the “MIC-only” era to the current antimicrobial resistance mechanism-driven framework. Key issues addressed include the clinical limitations of prior clinical breakpoints, challenges in balancing sensitivity and specificity of screening criteria to guide carbapenemase testing in different settings, and the expanding role of rapid phenotypic and molecular detection methods. Revisions to the EDTA-modified carbapenem inactivation method (eCIM) are discussed in light of increasing co-production of metallo-beta-lactamase and serine-carbapenemases. Reintegration of carbapenemase testing into clinical workflows highlights the role of the clinical microbiology laboratory as a critical component of antimicrobial stewardship.

journals.asm.org

Exploring pip/tazo PTA for Pseudomonas using popPK simulation. Key finds: 30min infusions fall short of 90% PTA at MIC 16; prolonged infusion helps, but neutropenic fever population sees the biggest drop in PTA. ~46% of susceptible PsA isolates carry blaOXA-2 — tazobactam matters more than I thought

Exploring Piperacillin/Tazobactam Probability of Target Attainment (PTA) in Pseudomonas | Everyday Is A School Day

Exploring pip/tazo PTA for Pseudomonas using popPK simulation. Key finds: 30-min infusions fall short of 90% PTA at MIC 16; prolonged infusion helps, but neutropenic fever population sees the biggest ...

kenkoonwong.com